CRT0044876

Research use only, not for human use.

CRT0044876 is a potent and selective APE1 inhibitor with IC50 of ~3 μM.

CRT0044876 is a potent BER inhibitor or DNA Base Excision Repair Pathway Inhibitor (APE1 IC50 - 3 microM). CRT0044876 potentiates the cytotoxicity of several DNA base-targeting compounds, with accumulation of apurinic sites.

A key step in BER is the processing of an apurinic/apyrimidinic (AP) site intermediate by an AP endonuclease. CRT0044876 has an IC50 for inhibition of APE1 of ～3 μM and not only inhibits AP site cleavage catalyzed by purified APE1, but also cleavage directed by APE1 in a HeLa whole cell extract. CRT0044876 inhibits the 3′-phosphoglycolate diesterase activity of APE1 with an IC50 of ～5 μM.CRT0044876 inhibits both the exonuclease and AP endonuclease activities of exonuclease III, but shows no inhibitory activity towards endonuclease IV. CRT0044876 has minimal effects on BamHI restriction endonuclease or topoisomerase I even at CRT0044876 concentrations of 100 μM.At non-toxic concentrations, CRT0044876 potentiates the cytotoxicity of several DNA damaging agents, which generate damage that is repaired in the BER pathway, including some currently-used anticancer drugs. The combination of MMS and CRT0044876 leads to a synergistic increase in the level of AP sites. Consistent with CRT0044876 being a specific BER inhibitor, a strong potentiation of hmdUrd cytotoxicity is seen in CRT0044876-treated cells (HT1080 cells).

——

CRT0044876 | CRT-0044876 | CRT 0044876

Others

Other Targets

APE1

Others-Field

——

6960-45-8

206.15

C9H6N2O4

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (242.54 mM)

OC(=O)C1=CC2=C(N1)C(=CC=C2)[N+]([O-])=O

7-Nitro-1H-indole-2-carboxylic acid.

(-20℃)

With Ice Pack

≥ 2 years